콘텐츠로 건너뛰기
주식/증권 ➡️ 중립

How S&P 500 Giant Pfizer Is Tackling Hard-To-Treat Cancers

요약

Pfizer said Sunday its Braftovi-tied regimen nearly doubled the length of time colon cancer patients lived without getting sicker.